Pfizer to offer top-selling COVID-19 vaccines, medicines at low cost to poor nations – National |

Pfizer mentioned Wednesday that it’s going to present practically two dozen merchandise, together with its top-selling COVID-19 vaccine and remedy, at not-for-profit costs in a number of the world’s poorest nations.

The drugmaker introduced this system on the World Financial Discussion board’s annual gathering in Davos, Switzerland, and mentioned it was aimed toward enhancing well being fairness in 45 lower-income nations. Many of the nations are in Africa, however the record additionally consists of Haiti, Syria, Cambodia and North Korea.

Learn extra:

Generic versions of Pfizer’s Paxlovid to be sold in low-income countries for $25 or less

The merchandise, that are extensively out there within the U.S. and the European Union, embrace 23 medicines and vaccines that deal with infectious illnesses, some cancers and uncommon and inflammatory circumstances. Firm spokeswoman Pam Eisele mentioned solely a small variety of the medicines and vaccines are at present out there within the 45 nations.

Story continues under commercial

New York-based Pfizer will cost solely manufacturing prices and “minimal” distribution bills, Eisele mentioned. It is going to adjust to any sanctions and all different relevant legal guidelines.

The drugmaker additionally plans to supply assist with public training, coaching for well being care suppliers and drug provide administration.

Click to play video: 'Accessibility of Pfizer pill in Canada raises ethical questions'

Accessibility of Pfizer capsule in Canada raises moral questions

Accessibility of Pfizer capsule in Canada raises moral questions – Jan 19, 2022

“What we found by means of the pandemic was that offer was not sufficient to resolve the problems that these nations are having,” Pfizer Chairman and CEO Albert Bourla mentioned Wednesday throughout a chat at Davos.

He famous that billions of doses of the corporate’s COVID-19 vaccine, Comirnaty, have been provided without spending a dime to low-income nations, primarily by means of the U.S. authorities, however these doses can’t be used proper now.

Pfizer’s plan will nonetheless depart many middle-income nations and different nations “to pay by means of the nostril for lifesaving medicine they will’t afford,” mentioned an announcement from the Individuals’s Vaccine Alliance, a grouping of human rights organizations advocating for broader sharing of vaccines and their underlying know-how. “We shouldn’t hail pandemic profiteers as heroes, even once they make certified gestures like this,” the assertion mentioned.

Story continues under commercial

Learn extra:

Paxlovid oral treatment fails to prevent COVID-19 in household members: Pfizer

Earlier this month, the top of the World Well being Group known as on Pfizer to make its COVID-19 remedy extra extensively out there in poorer nations.

Comirnaty introduced in practically $37 billion in gross sales final yr, and analysts count on the corporate’s COVID-19 remedy Paxlovid so as to add virtually $24 billion this yr, in keeping with the information agency FactSet.

© 2022 The Canadian Press

Leave a Comment